Compare ANGH & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANGH | CTXR |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.1M | 19.8M |
| IPO Year | N/A | N/A |
| Metric | ANGH | CTXR |
|---|---|---|
| Price | $4.15 | $0.85 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 2.2M | 1.4M |
| Earning Date | 04-30-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $96,736,848.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $147.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 85.06 | N/A |
| 52 Week Low | $2.25 | $0.63 |
| 52 Week High | $8.40 | $4.51 |
| Indicator | ANGH | CTXR |
|---|---|---|
| Relative Strength Index (RSI) | 79.17 | 38.71 |
| Support Level | $2.30 | $0.76 |
| Resistance Level | $2.71 | $1.18 |
| Average True Range (ATR) | 0.30 | 0.11 |
| MACD | 0.16 | -0.02 |
| Stochastic Oscillator | 98.97 | 38.90 |
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.